(Natural News) Alzheimer’s disease is often presaged by a condition called mild cognitive impairment (MCI). MCI is the stage between the decline of cognition expected during normal aging and the onset of dementia and Alzheimer’s disease. MCI has a very common sub-type called amnestic MCI (aMCI). It is characterized by the impairment of episodic memory; but […]

(Natural News) The efficacy and safety of a Chinese herbal formulation that aims to reduce certain symptoms of mild cognitive impairment (MCI) was recently tested with promising results. This study focused on treating the most common sub-type of MCI called amnestic MCI (aMCI). It is characterized by the impairment of episodic memory without the impairment […]

(Natural News) Donepezil is an acetylcholinesterase inhibitor approved by the Food and Drug Administration (FDA) in the United States to treat Alzheimer’s disease. Since mild cognitive impairment (MCI), or the phase between normal age-related brain decline and dementia, displays similar symptoms to Alzheimer’s, many physicians also prescribe this drug off-label to patients with MCI. Researchers […]